Nagano, Japan

Kozo Miyasaka

USPTO Granted Patents = 3 


 

Average Co-Inventor Count = 11.5

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2016-2025

Loading Chart...
Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Innovations in Cancer Treatment by Kozo Miyasaka

Introduction

Kozo Miyasaka, based in Nagano, Japan, is a notable inventor in the pharmaceutical field, particularly focused on innovative treatments for cancer. With a total of three patents to his name, Miyasaka has made significant strides in developing compounds that activate immune cells and combat resistance to established therapies.

Latest Patents

Miyasaka's latest patents include the development of two pivotal compounds:

1. **Pyridazinyl-thiazolecarboxamide Compound**: This compound serves as a critical active ingredient in pharmaceutical compositions aimed at treating cancer. Specifically, it addresses cancer associated with the activation of immune cells or those resistant to anti-PD-1 antibody and anti-PD-L1 antibody therapies. Through extensive studies, Miyasaka and his team have verified that this compound exhibits a DGK ξ (DGKzeta) inhibitory effect, making it a promising therapeutic agent in cancer treatment.

2. **Heteroaryl Carboxamide Compound**: Similar to his previous invention, this compound also functions as an essential pharmaceutical ingredient for treating cancers linked to immune cell activation or resistance to anti-PD-1 and anti-PD-L1 therapies. Miyasaka’s research demonstrates that this compound possesses a DGK ξ inhibitory effect as well, contributing to its potential as a cancer therapy.

Career Highlights

Kozo Miyasaka has been associated with prestigious companies such as Astellas Pharma GmbH and Kotobuki Pharmaceutical Co. Ltd. His work in these well-known institutions has fueled his passion for developing innovative solutions in oncology, leading to groundbreaking discoveries.

Collaborations

Throughout his career, Miyasaka has collaborated with esteemed professionals in the field, including Hiroshi Tomiyama and Yoshinori Iwai. These partnerships have significantly enhanced his research capabilities and contributed to the success of his innovative projects.

Conclusion

Kozo Miyasaka's contributions to pharmaceutical inventions demonstrate his commitment to advancing cancer treatment. His innovative compounds not only hold promise for enhancing the efficacy of therapies but also showcase the potential of targeted approaches in combating cancer. As he continues to develop new solutions, the impact of his work will undoubtedly resonate within the medical community and beyond.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…